Hub : Traits :

Smoking status: Previous

20 significantly associated models · 13 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 1 154401972 155762509 1 1 2.9e-07 1.9e-07 0.2490 95 EFNA1
2 2 47780684 48277490 1 1 1.5e-07 1.5e-07 0.0677 88 MSH6
3 3 84317575 86808226 1 1 8.4e-13 2.1e-13 0.0587 93 CADM2
4 6 110588546 112501537 3 1 9.3e-10 9.4e-11 0.0256 88 GTF3C6
5 7 2646223 5003373 1 1 1.3e-08 7.3e-10 0.0084 82 SDK1
6 12 111193499 113137832 4 1 3.4e-08 1.7e-10 0.0002 66 ALDH2
7 16 69062879 70473934 2 1 4.5e-08 2.1e-07 0.8370 100 NOB1

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Bipolar Disorder (2018) 1.82 1 0 0.0 0.00 1.0e+00 CADM2
Depressed Affect (Nagel 2018) 2.41 2 0 0.0 0.00 1.0e+00 ALDH2 EFNA1
Depression (Nagel 2018) 2.40 1 0 0.0 0.00 1.0e+00 ALDH2
Intelligence (Savage-Jansen 2018) 1.57 1 0 0.0 0.00 1.0e+00 MSH6
Neuroticism (Nagel 2018) 1.62 1 0 0.0 0.00 1.0e+00 CADM2
Worry (Nagel 2018) 5.90 2 1 2.2 0.00 1.0e+00 CADM2 GTF3C6
Crohns Disease (2017) 2.79 1 1 2.2 0.00 1.0e+00 EFNA1
Irritable Bowel Disease (IBD) 4.16 2 1 2.2 0.00 1.0e+00 ALDH2 EFNA1
Ulcerative Colitis (UC) 3.81 2 0 0.0 0.00 1.0e+00 ALDH2 EFNA1
Reaction Time 3.71 1 1 2.2 0.00 1.0e+00 ALDH2
Breast Cancer 2.02 1 0 0.0 0.00 1.0e+00 EFNA1
Coronary Artery Disease (CAD) 3.31 1 0 0.0 0.00 1.0e+00 ALDH2
Crohns Disease (2012) 2.20 1 0 0.0 0.00 1.0e+00 EFNA1
Fasting Glucose 2.56 1 0 0.0 0.00 1.0e+00 MSH6
LDL Cholesterol 4.51 1 1 2.2 0.00 1.0e+00 ALDH2
Lupus 2.02 1 0 0.0 0.00 1.0e+00 ALDH2
Primary Biliary Cirrhosis 2.99 1 0 0.0 0.00 1.0e+00 ALDH2
Rheumatoid Arthritis 1.96 1 0 0.0 0.00 1.0e+00 ALDH2
Ulcerative Colitis 1.84 1 0 0.0 0.00 1.0e+00 EFNA1
Blood Eosinophil Count 18.63 2 1 2.2 0.00 1.0e+00 ALDH2 GTF3C6
Blood Platelet Count 2.94 4 3 6.7 0.79 2.1e-01 ALDH2 EFNA1 MSH6 NOB1
Blood Red Count 5.25 3 3 6.7 0.00 1.0e+00 ALDH2 EFNA1 GTF3C6
Blood White Count 8.95 1 1 2.2 0.00 1.0e+00 ALDH2
Heel T-Score 1.43 3 1 2.2 0.00 1.0e+00 EFNA1 MSH6 NOB1
BMI 3.63 5 1 2.2 0.47 4.2e-01 ALDH2 CADM2 EFNA1 GTF3C6 NOB1
Height 0.44 2 1 2.2 0.00 1.0e+00 ALDH2 NOB1
Waist Hip Ratio (WHR) 1.83 3 0 0.0 0.00 1.0e+00 ALDH2 MSH6 SDK1
Systolic Blood Pressure 6.03 4 2 4.4 -0.16 8.4e-01 ALDH2 CADM2 NOB1 SDK1
Smoking Status 15.86 5 4 8.9 0.99 1.9e-03 CADM2 GTF3C6 MSH6 NOB1 SDK1
Allergy or Eczema 2.38 2 0 0.0 0.00 1.0e+00 ALDH2 EFNA1
Cardiovascular Disease 3.19 1 1 2.2 0.00 1.0e+00 ALDH2
Hypothyroidism (self reported) 13.14 1 1 2.2 0.00 1.0e+00 ALDH2
Lung FEV1/FVC ratio 1.05 2 0 0.0 0.00 1.0e+00 ALDH2 MSH6
Lung FVC 3.20 4 2 4.4 0.21 7.9e-01 ALDH2 EFNA1 MSH6 NOB1
Neuroticism 2.18 1 0 0.0 0.00 1.0e+00 CADM2
Chronotype (morning person) 3.33 2 1 2.2 0.00 1.0e+00 ALDH2 SDK1
Hair Pigment 0.69 3 2 4.4 0.00 1.0e+00 ALDH2 EFNA1 MSH6
Tanning 1.56 3 1 2.2 0.00 1.0e+00 ALDH2 CADM2 EFNA1
Hand grip strength (left) 3.68 2 1 2.2 0.00 1.0e+00 CADM2 NOB1
Number of treatments/medications taken 2.44 1 0 0.0 0.00 1.0e+00 ALDH2
Frequency of depressed mood in last 2 weeks 2.22 1 0 0.0 0.00 1.0e+00 MSH6
Systolic blood pressure, automated reading 3.94 2 1 2.2 0.00 1.0e+00 ALDH2 CADM2
Angina 2.91 1 0 0.0 0.00 1.0e+00 NOB1
Medication: Co-codamol 1.50 1 0 0.0 0.00 1.0e+00 MSH6
Impedance of leg (right) 3.02 3 2 4.4 0.00 1.0e+00 CADM2 EFNA1 NOB1
Leg fat-free mass (left) 3.19 3 1 2.2 0.00 1.0e+00 ALDH2 CADM2 EFNA1
Trunk fat percentage 1.98 3 0 0.0 0.00 1.0e+00 EFNA1 GTF3C6 NOB1
Hand grip strength (right) 2.44 2 0 0.0 0.00 1.0e+00 CADM2 NOB1
Current tobacco smoking 3.97 2 0 0.0 0.00 1.0e+00 CADM2 GTF3C6
Maternal smoking around birth 4.30 2 0 0.0 0.00 1.0e+00 GTF3C6 SDK1
Fed-up feelings 2.76 1 0 0.0 0.00 1.0e+00 ALDH2
Frequency of unenthusiasm / disinterest in last 2 weeks 2.21 1 0 0.0 0.00 1.0e+00 ALDH2
Taking other prescription medications 3.80 1 0 0.0 0.00 1.0e+00 ALDH2
Age when periods started (menarche) 2.59 2 0 0.0 0.00 1.0e+00 MSH6 NOB1
Heel bone mineral density (BMD) T-score, automated (left) 1.39 1 0 0.0 0.00 1.0e+00 EFNA1
High blood pressure 3.22 1 1 2.2 0.00 1.0e+00 ALDH2
Hayfever, allergic rhinitis or eczema 2.24 2 0 0.0 0.00 1.0e+00 ALDH2 EFNA1
Diverticular disease/diverticulitis (self-reported) 2.21 1 0 0.0 0.00 1.0e+00 ALDH2
Medication: Atenolol 3.86 1 0 0.0 0.00 1.0e+00 ALDH2
Medication: Levothyroxine sodium 11.27 1 1 2.2 0.00 1.0e+00 ALDH2
Body mass index (BMI) 4.01 5 1 2.2 0.45 4.5e-01 ALDH2 CADM2 EFNA1 GTF3C6 NOB1
Impedance of leg (left) 3.10 4 2 4.4 -0.16 8.4e-01 CADM2 EFNA1 NOB1 SDK1
Leg predicted mass (left) 3.16 3 1 2.2 0.00 1.0e+00 ALDH2 CADM2 EFNA1
Trunk fat mass 2.51 5 0 0.0 0.30 6.2e-01 ALDH2 CADM2 EFNA1 GTF3C6 NOB1
Waist circumference 3.11 4 1 2.2 0.63 3.7e-01 ALDH2 CADM2 GTF3C6 NOB1
Past tobacco smoking 21.92 7 6 13.3 -0.99 7.1e-06 ALDH2 CADM2 EFNA1 GTF3C6 MSH6 NOB1 SDK1
Nervous feelings 6.72 2 1 2.2 0.00 1.0e+00 CADM2 MSH6
Frequency of tenseness / restlessness in last 2 weeks 3.04 1 0 0.0 0.00 1.0e+00 ALDH2
Had other major operations 1.68 1 0 0.0 0.00 1.0e+00 SDK1
Forced vital capacity (FVC) 1.82 2 0 0.0 0.00 1.0e+00 MSH6 NOB1
Mouth/teeth dental problems 2.98 1 1 2.2 0.00 1.0e+00 EFNA1
Heart attack 3.69 2 0 0.0 0.00 1.0e+00 ALDH2 NOB1
Allergy 1.82 1 0 0.0 0.00 1.0e+00 EFNA1
Diabetes (self-reported) 2.52 1 0 0.0 0.00 1.0e+00 NOB1
Illnesses of siblings 1.69 1 0 0.0 0.00 1.0e+00 ALDH2
Neuroticism score 1.86 1 0 0.0 0.00 1.0e+00 CADM2
Weight 3.55 4 2 4.4 0.20 8.0e-01 ALDH2 CADM2 EFNA1 GTF3C6
Impedance of arm (right) 4.16 3 1 2.2 0.00 1.0e+00 ALDH2 CADM2 MSH6
Arm fat percentage (right) 2.74 4 0 0.0 0.54 4.6e-01 CADM2 EFNA1 GTF3C6 NOB1
Trunk fat-free mass 3.14 2 2 4.4 0.00 1.0e+00 ALDH2 CADM2
Hip circumference 3.18 2 2 4.4 0.00 1.0e+00 ALDH2 CADM2
Father's age at death 1.84 1 0 0.0 0.00 1.0e+00 ALDH2
Worrier / anxious feelings 7.14 2 1 2.2 0.00 1.0e+00 CADM2 GTF3C6
Frequency of tiredness / lethargy in last 2 weeks 1.99 1 0 0.0 0.00 1.0e+00 ALDH2
Number of live births 3.92 1 1 2.2 0.00 1.0e+00 CADM2
Forced expiratory volume in 1-second (FEV1) 1.85 1 0 0.0 0.00 1.0e+00 NOB1
Qualifications: A levels/AS levels or equivalent 2.26 2 0 0.0 0.00 1.0e+00 CADM2 MSH6
Mouth/teeth dental problems: Dentures 3.38 1 1 2.2 0.00 1.0e+00 EFNA1
Medication: Ibuprofen (e.g. Nurofen) 1.87 1 0 0.0 0.00 1.0e+00 ALDH2
Medication: Cholesterol lowering 1.93 1 0 0.0 0.00 1.0e+00 NOB1
Medication: Lansoprazole 2.83 1 0 0.0 0.00 1.0e+00 ALDH2
Forced expiratory volume in 1-second (FEV1), Best measure 1.92 1 0 0.0 0.00 1.0e+00 NOB1
Impedance of arm (left) 4.39 2 1 2.2 0.00 1.0e+00 ALDH2 CADM2
Arm fat mass (right) 3.49 5 1 2.2 0.35 5.6e-01 ALDH2 CADM2 EFNA1 GTF3C6 NOB1
Trunk predicted mass 3.15 2 2 4.4 0.00 1.0e+00 ALDH2 CADM2
Standing height 0.48 1 0 0.0 0.00 1.0e+00 ALDH2
Tense / 'highly strung' 2.58 1 0 0.0 0.00 1.0e+00 CADM2
Seen doctor (GP) for nerves, anxiety, tension or depression 1.59 1 0 0.0 0.00 1.0e+00 CADM2
Hair/balding pattern: Pattern 4 2.00 2 0 0.0 0.00 1.0e+00 EFNA1 MSH6
Birth weight of first child 3.41 1 1 2.2 0.00 1.0e+00 ALDH2
Ever highly irritable/argumentative for 2 days 1.97 1 0 0.0 0.00 1.0e+00 ALDH2
Qualifications: O levels/GCSEs or equivalent 1.42 1 0 0.0 0.00 1.0e+00 CADM2
Blood clot in the leg (DVT) 3.09 1 0 0.0 0.00 1.0e+00 ALDH2
Headache pain in last month 1.99 1 0 0.0 0.00 1.0e+00 ALDH2
Medication for cholesterol, blood pressure or diabetes 2.17 1 0 0.0 0.00 1.0e+00 ALDH2
Gout (self-reported) 3.77 2 0 0.0 0.00 1.0e+00 ALDH2 EFNA1
Hypothyroidism/myxoedema (self-reported) 11.16 1 1 2.2 0.00 1.0e+00 ALDH2
Birth weight 2.59 1 1 2.2 0.00 1.0e+00 ALDH2
High blood pressure (siblings) 2.06 1 0 0.0 0.00 1.0e+00 ALDH2
Forced vital capacity (FVC), Best measure 2.01 2 0 0.0 0.00 1.0e+00 MSH6 NOB1
Body fat percentage 2.04 4 0 0.0 0.63 3.7e-01 CADM2 EFNA1 GTF3C6 NOB1
Leg fat percentage (right) 2.28 2 0 0.0 0.00 1.0e+00 CADM2 GTF3C6
Arm fat-free mass (right) 3.92 2 2 4.4 0.00 1.0e+00 ALDH2 CADM2
Comparative body size at age 10 3.51 1 1 2.2 0.00 1.0e+00 CADM2
Number of full brothers 3.62 1 0 0.0 0.00 1.0e+00 CADM2
Worry too long after embarrassment 2.57 1 0 0.0 0.00 1.0e+00 CADM2
Wheeze or whistling in the chest in last year 2.11 1 0 0.0 0.00 1.0e+00 EFNA1
Number of children fathered 5.56 1 1 2.2 0.00 1.0e+00 CADM2
Qualifications: College or University degree 2.73 2 1 2.2 0.00 1.0e+00 CADM2 SDK1
Medication for pain relief, constipation, heartburn 1.50 1 0 0.0 0.00 1.0e+00 GTF3C6
Medication: Blood pressure 2.90 1 0 0.0 0.00 1.0e+00 ALDH2
Angina (self-reported) 2.88 1 0 0.0 0.00 1.0e+00 NOB1
Medication: Allopurinol 3.13 2 0 0.0 0.00 1.0e+00 ALDH2 EFNA1
Mean time to correctly identify matches 3.62 1 1 2.2 0.00 1.0e+00 ALDH2
Heart disease (mother) 2.78 1 0 0.0 0.00 1.0e+00 ALDH2
Reproduciblity of spirometry measurement using ERS/ATS criteria 2.03 1 0 0.0 0.00 1.0e+00 EFNA1
Whole body fat mass 3.04 5 1 2.2 0.36 5.5e-01 ALDH2 CADM2 EFNA1 GTF3C6 NOB1
Leg fat mass (right) 3.63 4 1 2.2 0.63 3.7e-01 ALDH2 CADM2 GTF3C6 NOB1
Arm predicted mass (right) 3.87 2 2 4.4 0.00 1.0e+00 ALDH2 CADM2
Pulse rate, automated reading 1.91 1 1 2.2 0.00 1.0e+00 MSH6
Alcohol intake frequency. 2.39 1 0 0.0 0.00 1.0e+00 CADM2
Comparative height size at age 10 1.14 1 1 2.2 0.00 1.0e+00 ALDH2
Number of full sisters 4.06 1 1 2.2 0.00 1.0e+00 CADM2
Suffer from 'nerves' 4.35 1 1 2.2 0.00 1.0e+00 CADM2
Qualifications: NVQ or HND or HNC or equivalent 4.46 2 0 0.0 0.00 1.0e+00 ALDH2 SDK1
Hypertension (Self-reported) 2.69 1 1 2.2 0.00 1.0e+00 ALDH2
Illnesses of father: Heart disease 2.85 1 0 0.0 0.00 1.0e+00 ALDH2
Forced expiratory volume in 1-second (FEV1), predicted 1.18 1 0 0.0 0.00 1.0e+00 SDK1
Whole body fat-free mass 3.26 2 2 4.4 0.00 1.0e+00 ALDH2 CADM2
Leg fat-free mass (right) 2.99 3 1 2.2 0.00 1.0e+00 ALDH2 CADM2 EFNA1
Arm fat percentage (left) 2.75 4 0 0.0 0.54 4.6e-01 CADM2 EFNA1 GTF3C6 NOB1
Mood swings 1.86 1 0 0.0 0.00 1.0e+00 ALDH2
Loneliness, isolation 2.86 1 0 0.0 0.00 1.0e+00 ALDH2
Long-standing illness, disability or infirmity 3.65 1 0 0.0 0.00 1.0e+00 GTF3C6
Diabetes diagnosed by doctor 2.77 1 0 0.0 0.00 1.0e+00 NOB1
Ever had stillbirth, spontaneous miscarriage or termination 2.56 1 0 0.0 0.00 1.0e+00 CADM2
Qualifications: nursing, teaching 2.85 2 0 0.0 0.00 1.0e+00 CADM2 SDK1
Mouth/teeth dental problems: Mouth ulcers 1.75 1 0 0.0 0.00 1.0e+00 CADM2
Medication for cholesterol 2.48 1 0 0.0 0.00 1.0e+00 ALDH2
Back pain experienced in last month 3.17 1 0 0.0 0.00 1.0e+00 ALDH2
Medication: Gliclazide 2.34 1 0 0.0 0.00 1.0e+00 EFNA1
Illnesses of father: None of the above (group 1) 1.87 1 0 0.0 0.00 1.0e+00 ALDH2
Smoking status: Current 4.63 3 0 0.0 0.00 1.0e+00 ALDH2 CADM2 GTF3C6
Forced expiratory volume in 1-second (FEV1), predicted percentage 1.43 1 0 0.0 0.00 1.0e+00 NOB1
Whole body water mass 3.31 2 2 4.4 0.00 1.0e+00 ALDH2 CADM2
Leg predicted mass (right) 2.94 3 1 2.2 0.00 1.0e+00 ALDH2 CADM2 EFNA1
Arm fat mass (left) 3.71 5 1 2.2 0.38 5.2e-01 ALDH2 CADM2 EFNA1 GTF3C6 NOB1
Number of self-reported non-cancer illnesses 3.26 1 0 0.0 0.00 1.0e+00 ALDH2
Miserableness 1.45 1 0 0.0 0.00 1.0e+00 EFNA1
Wears glasses or contact lenses 3.14 1 0 0.0 0.00 1.0e+00 CADM2
Financial situation satisfaction 3.62 2 0 0.0 0.00 1.0e+00 CADM2 NOB1
Commuting to job workplace: Public transport 2.69 1 0 0.0 0.00 1.0e+00 CADM2
Medication: Blood pressure 2.93 1 1 2.2 0.00 1.0e+00 ALDH2
High cholesterol (Self-reported) 1.95 1 0 0.0 0.00 1.0e+00 EFNA1
Medication: Bendroflumethiazide 1.31 1 0 0.0 0.00 1.0e+00 ALDH2
Medication: Atorvastatin 2.01 1 0 0.0 0.00 1.0e+00 EFNA1
Alcohol drinker status: Never 2.84 1 0 0.0 0.00 1.0e+00 CADM2
Ever smoked 16.14 7 3 6.7 0.98 7.2e-05 ALDH2 CADM2 EFNA1 GTF3C6 MSH6 NOB1 SDK1
Basal metabolic rate 3.44 2 2 4.4 0.00 1.0e+00 ALDH2 CADM2
Leg fat percentage (left) 2.33 2 0 0.0 0.00 1.0e+00 CADM2 GTF3C6
Arm fat-free mass (left) 4.09 2 2 4.4 0.00 1.0e+00 ALDH2 CADM2
Average weekly beer plus cider intake 3.49 1 0 0.0 0.00 1.0e+00 CADM2
Risk taking 10.15 2 1 2.2 0.00 1.0e+00 CADM2 NOB1
Age started oral contraceptive pill 4.04 1 0 0.0 0.00 1.0e+00 CADM2
Diastolic blood pressure, automated reading 4.89 2 1 2.2 0.00 1.0e+00 ALDH2 EFNA1
Vascular/heart problems diagnosed by doctor 3.16 1 1 2.2 0.00 1.0e+00 ALDH2
Pain experienced in last month 3.60 2 0 0.0 0.00 1.0e+00 ALDH2 EFNA1
Heart attack/myocardial infarction (self-reported) 3.59 2 0 0.0 0.00 1.0e+00 ALDH2 NOB1
Deep venous thrombosis (DVT) (self-reported) 3.00 1 0 0.0 0.00 1.0e+00 ALDH2
Impedance of whole body 3.65 2 1 2.2 0.00 1.0e+00 ALDH2 CADM2
Leg fat mass (left) 3.67 4 1 2.2 0.65 3.5e-01 ALDH2 CADM2 GTF3C6 NOB1
Arm predicted mass (left) 4.04 2 2 4.4 0.00 1.0e+00 ALDH2 CADM2

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 1 0.029 1.5
GTEx Adipose Visceral Omentum 0 0.000 1.6
GTEx Adrenal Gland 0 0.000 1.5
GTEx Artery Aorta 0 0.000 1.5
GTEx Artery Coronary 0 0.000 1.6
GTEx Artery Tibial 0 0.000 1.5
GTEx Brain Caudate basal ganglia 0 0.000 1.5
GTEx Brain Cerebellar Hemisphere 0 0.000 1.7
GTEx Brain Cerebellum 4 0.202 1.7
GTEx Brain Cortex 0 0.000 1.6
GTEx Brain Frontal Cortex BA9 0 0.000 1.6
GTEx Brain Hippocampus 0 0.000 1.6
GTEx Brain Hypothalamus 1 0.169 1.7
GTEx Brain Nucleus accumbens basal ganglia 0 0.000 1.5
GTEx Brain Putamen basal ganglia 0 0.000 1.4
GTEx Breast Mammary Tissue 0 0.000 1.6
GTEx Breast Mammary Tissue (Male) 0 0.000 1.6
GTEx Breast Mammary Tissue (Female) 0 0.000 1.5
GTEx Cells EBV-transformed lymphocytes 0 0.000 1.6
GTEx Cells Transformed fibroblasts 0 0.000 1.5
GTEx Colon Sigmoid 0 0.000 1.6
GTEx Colon Transverse 1 0.048 1.6
GTEx Esophagus Gastroesophageal Junction 0 0.000 1.6
GTEx Esophagus Mucosa 0 0.000 1.5
GTEx Esophagus Muscularis 1 0.031 1.6
GTEx Heart Atrial Appendage 0 0.000 1.5
GTEx Heart Left Ventricle 0 0.000 1.6
GTEx Liver 0 0.000 1.5
GTEx Lung 0 0.000 1.6
GTEx Muscle Skeletal 1 0.035 1.6
GTEx Nerve Tibial 0 0.000 1.5
GTEx Ovary 0 0.000 1.6
GTEx Pancreas 0 0.000 1.7
GTEx Pituitary 0 0.000 1.6
GTEx Prostate 0 0.000 1.7
GTEx Skin Not Sun Exposed Suprapubic 0 0.000 1.6
GTEx Skin Sun Exposed Lower leg 1 0.027 1.6
GTEx Small Intestine Terminal Ileum 0 0.000 1.6
GTEx Spleen 0 0.000 1.6
GTEx Stomach 1 0.069 1.5
GTEx Testis 0 0.000 1.6
GTEx Thyroid 0 0.000 1.5
GTEx Uterus 0 0.000 1.6
GTEx Vagina 0 0.000 1.5
GTEx Whole Blood 0 0.000 1.6
METSIM Adipose 2 0.043 1.5
NTR Blood 0 0.000 1.5
ROSMAP Brain Pre-frontal Cortex 0 0.000 1.5
YFS Blood 0 0.000 1.5
CommonMind Brain Pre-frontal Cortex 1 0.019 1.5
The Cancer Genome Atlas Bladder Urothelial Carcinoma 0 0.000 1.4
The Cancer Genome Atlas Breast Invasive Carcinoma 0 0.000 1.5
The Cancer Genome Atlas Cervical Squamous Cell Carcinoma 0 0.000 1.4
The Cancer Genome Atlas Colon Adenocarcinoma 0 0.000 1.4
The Cancer Genome Atlas Esophageal Carcinoma 0 0.000 1.4
The Cancer Genome Atlas Glioblastoma Multiforme 0 0.000 1.5
The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma 0 0.000 1.4
The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma 0 0.000 1.4
The Cancer Genome Atlas Kidney Renal Papillary Cell Carcinoma 0 0.000 1.4
The Cancer Genome Atlas Brain Lower Grade Glioma 2 0.046 1.5
The Cancer Genome Atlas Liver Hepatocellular Carcinoma 0 0.000 1.4
The Cancer Genome Atlas Lung Adenocarcinoma 1 0.034 1.4
The Cancer Genome Atlas Lung Squamous Cell Carcinoma 1 0.040 1.4
The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma 0 0.000 1.5
The Cancer Genome Atlas Pancreatic Adenocarcinoma 0 0.000 1.4
The Cancer Genome Atlas Pheochromocytoma and Paraganglioma 1 0.075 1.5
The Cancer Genome Atlas Prostate Adenocarcinoma 0 0.000 1.4
The Cancer Genome Atlas Rectum Adenocarcinoma 0 0.000 1.4
The Cancer Genome Atlas Soft Tissue Sarcoma 0 0.000 1.4
The Cancer Genome Atlas Skin Cutaneous Melanoma 0 0.000 1.4
The Cancer Genome Atlas Stomach Adenocarcinoma 0 0.000 1.3
The Cancer Genome Atlas Testicular Germ Cell Tumors 0 0.000 1.4
The Cancer Genome Atlas Thyroid Carcinoma 1 0.019 1.4
The Cancer Genome Atlas Uterine Corpus Endometrial Carcinoma 0 0.000 1.2